annual cash & cash equivalents:
$71.33M-$17.06M(-19.30%)Summary
- As of today (September 3, 2025), ARQT annual cash & cash equivalents is $71.33 million, with the most recent change of -$17.06 million (-19.30%) on December 31, 2024.
- During the last 3 years, ARQT annual cash & cash equivalents has fallen by -$25.11 million (-26.04%).
- ARQT annual cash & cash equivalents is now -26.04% below its all-time high of $96.45 million, reached on December 31, 2021.
Performance
ARQT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$191.13M-$7.57M(-3.81%)Summary
- As of today (September 3, 2025), ARQT quarterly cash & cash equivalents is $191.13 million, with the most recent change of -$7.57 million (-3.81%) on June 30, 2025.
- Over the past year, ARQT quarterly cash & cash equivalents has dropped by -$171.92 million (-47.35%).
- ARQT quarterly cash & cash equivalents is now -60.03% below its all-time high of $478.20 million, reached on September 30, 2022.
Performance
ARQT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ARQT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -47.4% |
| 3 y3 years | -26.0% | -32.6% |
| 5 y5 years | +12.6% | -14.7% |
ARQT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.0% | +33.0% | -60.0% | at low |
| 5 y | 5-year | -26.0% | +33.0% | -60.0% | +0.8% |
| alltime | all time | -26.0% | +1987.0% | -60.0% | +659.1% |
ARQT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $191.13M(-3.8%) |
| Mar 2025 | - | $198.71M(-13.1%) |
| Dec 2024 | $71.33M(-19.3%) | $228.57M(-31.0%) |
| Sep 2024 | - | $331.18M(-8.8%) |
| Jun 2024 | - | $363.05M(-10.2%) |
| Mar 2024 | - | $404.48M(+48.3%) |
| Dec 2023 | $88.40M(+64.8%) | $272.79M(+19.6%) |
| Sep 2023 | - | $228.04M(-15.4%) |
| Jun 2023 | - | $269.60M(-19.1%) |
| Mar 2023 | - | $333.33M(-18.9%) |
| Dec 2022 | $53.64M | $410.82M(-14.1%) |
| Sep 2022 | - | $478.20M(+68.7%) |
| Jun 2022 | - | $283.40M(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $344.83M(-11.3%) |
| Dec 2021 | $96.45M(+48.2%) | $388.60M(+5.4%) |
| Sep 2021 | - | $368.81M(-10.2%) |
| Jun 2021 | - | $410.91M(-8.0%) |
| Mar 2021 | - | $446.47M(+56.1%) |
| Dec 2020 | $65.08M(+2.8%) | $285.98M(+50.7%) |
| Sep 2020 | - | $189.71M(-15.3%) |
| Jun 2020 | - | $223.97M(-10.2%) |
| Mar 2020 | - | $249.32M(+146.2%) |
| Dec 2019 | $63.34M(+60.8%) | $101.27M(+302.2%) |
| Sep 2019 | - | $25.18M(-29.8%) |
| Jun 2019 | - | $35.86M(-29.6%) |
| Dec 2018 | $39.39M(+1052.5%) | $50.94M |
| Dec 2017 | $3.42M | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ARQT is $71.33M
What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual cash & cash equivalents is $96.45M
What is Arcutis Biotherapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ARQT annual cash & cash equivalents has changed by -$17.06M (-19.30%)
What is Arcutis Biotherapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ARQT is $191.13M
What is the all time high quarterly cash & cash equivalents for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly cash & cash equivalents is $478.20M
What is Arcutis Biotherapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ARQT quarterly cash & cash equivalents has changed by -$171.92M (-47.35%)